Clinical Trials List
2022-05-02 - 2028-12-01
Phase III
Recruiting6
ICD-10C61
Malignant neoplasm of prostate
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9185
Malignant neoplasm of prostate
-
Trial Applicant
ELI LILLY AND COMPANY(TAIWAN), INC.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/02/01
Investigators and Locations
Co-Principal Investigator
- PO-HUNG LIN Division of Urology
- 黃文冠 Division of Hematology & Oncology
- Jing-Ren Tseng Division of Nuclear Medicine
- Hong-Cheng Gan Division of Urology
- Kai-Jie Yu Division of Urology
- Po-Jung Su Division of Hematology & Oncology
- Rita cheng Division of Urology
- I-hung Shao Division of Urology
- Yung-Chang Lin Division of Hematology & Oncology
- 張境夫 Division of Hematology & Oncology
- Yuan-Cheng Chu Division of Urology
- 黃亮鋼 Division of Hematology & Oncology
- 張鈞弼 Division of Radiology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Yen-Hwa Chang Division of Urology
- Tzu-chun Wei Division of Urology
- Chien-Hsin Ting Division of Nuclear Medicine
- Tzu-Ping Lin Division of Urology
- 陳威任 Division of Urology
- Hsiao-Jen Chung Division of Urology
- Tzu-Hao Huang Division of Urology
- Jia-An Hong Division of Radiology
- William Huang Division of Urology
- Chih-Chieh Lin Division of Urology
- I-Shen Huang Division of Urology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 劉詩彬 Division of Urology
- YI-KAI CHANG Division of Urology
- Yu-Chieh Tsai Division of Hematology & Oncology
- CHING-CHU LU Division of Nuclear Medicine
- CHUNG-HSIN CHEN Division of Urology
- YU-CHUAN LU Division of Urology
- FU-JEN HSUEH Division of Hematology & Oncology
- JHE-CYUAN GUO Division of Hematology & Oncology
- Yeong-Shiau Pu Division of Urology
- SHUO-MENG WANG Division of Urology
- Ying-Chun Shen Division of Hematology & Oncology
- 王中傑 Division of Others
- 闕士傑 Division of Urology
- JIAN-HUA HONG Division of Urology
- 曾啟新 Division of Urology
- - - Division of Radiology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Wu-Chou Su Division of Hematology & Oncology
- Che-Yuan Hu Division of Urology
- Jiann-Hui Ou Division of Urology
- 楊舜如 Division of Hematology & Oncology
- Yuh-Shyan Tsai Division of Urology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 盧嘉文 Division of Urology
- Cheng-Che Chen Division of Urology
- 張瓈文 Division of Urology
- 林雁婷 Division of Radiology
- 賴谷順 Division of Urology
- Chuan-Shu Chen Division of Urology
- Chia-Yen Lin Division of Urology
- 梅承恩 Division of Emergency Medicine
- Shian-Shiang Wang Division of Urology
- 王樹吉 Division of Urology
- JU-CHUAN HU Division of General Surgery
- 蔡世傳 Division of Nuclear Medicine
- 裘坤元 Division of Urology
- Jian-Ri Li Division of Urology
- 洪晟鈞 Division of Urology
- 廖博崎 Division of General Internal Medicine
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Chi-Rei Yang Division of Urology
- Po-Jen Hsiao Division of Urology
- Po-Fan Hsieh Division of Urology
- Chi-Ping Huang Division of Urology
- 陳冠亨 Division of Urology
- Hsi-Chin Wu Division of Urology
- Yi-Huei Chang Division of Urology
- 謝德鈞 Division of Nuclear Medicine
- Wei-Ching Lin Division of Radiology
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
18-36 participants
-
Global
900 participants
